Randomised trial of intradermal Mycobacterium vaccae or intradermal hepatitis B immunisation in children with HIV infection.

[1]  J. Habbema,et al.  Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  C. F. von Reyn,et al.  Cellular immune responses to mycobacteria in healthy and human immunodeficiency virus-positive subjects in the United States after a five-dose schedule of Mycobacterium vaccae vaccine. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  D. Jacobs,et al.  Cellular immune responses to four doses of percutaneous bacille Calmette-Guérin in healthy adults. , 1998, The Journal of infectious diseases.

[4]  I. Nath.  A vaccine for leprosy , 1998, Nature Medicine.

[5]  D. Williams,et al.  Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. , 1998, The Journal of infectious diseases.

[6]  J. Watson,et al.  Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis , 1997, Infection and immunity.

[7]  G. Rook,et al.  Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection , 1997, Infection and immunity.

[8]  R. Arbeit,et al.  Immunization of HIV-infected adults with a three-dose series of inactivated Mycobacterium vaccae. , 1997, The American journal of the medical sciences.

[9]  C. F. von Reyn,et al.  Immunization of healthy adult subjects in the United States with inactivated Mycobacterium vaccae administered in a three-dose series. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  J. Lamb,et al.  Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae , 1997, Infection and immunity.

[11]  A. Tosteson,et al.  The risks and benefits of childhood bacille Calmette‐Guérin immunization among adults with AIDS , 1997 .

[12]  J Coste,et al.  Reliability of Tuberculin Skin Test Measurement , 1997, Annals of Internal Medicine.

[13]  C. Horsburgh,et al.  Protection from Mycobacterium avium complex disease in human immunodeficiency virus-infected persons with a history of tuberculosis. , 1996, The Journal of infectious diseases.

[14]  A. Tosteson,et al.  The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS , 1996, AIDS.

[15]  B. Cooper,et al.  Immunization with high-dose intradermal recombinant hepatitis B vaccine in healthcare workers who failed to respond to intramuscular vaccination. , 1995, Infection control and hospital epidemiology.

[16]  L. Larsson,et al.  Sensitivity to sensitins and tuberculin in Swedish children. Part 5: A study of school children in an inland rural area. , 1993, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  J. King,et al.  Comparison of the immunogenicity of hepatitis B vaccine administered intradermally and intramuscularly. , 1990, Reviews of infectious diseases.

[18]  R. Dubos.  ACQUIRED IMMUNITY TO TUBERCULOSIS. , 1964, The American review of respiratory disease.

[19]  V. Rønnov-Jessen.  Blood-volume and tolerance to pentolinium in the treatment of hypertension. , 1960, Lancet.